Hoth Therapeutics

(NASDAQ) HOTH

Current Price$1.02

Market Cap$24.55M

Since IPO (2019)-99%

5 Year-97%

1 Year-15%

1 Month+80%

Hoth Therapeutics Financials at a Glance

Market Cap

$24.55M

Revenue (TTM)

$0.00

Net Income (TTM)

-$11.69M

EPS (TTM)

-$0.81

P/E Ratio

-1.36

Dividend

$0.00

Beta (Volatility)

0.98 (Low)

Dividend

$0.00

Beta (Volatility)

0.98 (Low)

Price

$1.02

Volume

1,498,805.447

Open

$1.08

Price

$1.02

Volume

1,498,805.447

Open

$1.08

Previous Close

$1.10

Daily Range

$1.00 - $1.12

52-Week Range

$0.49 - $2.45

Estimated Earnings Date

Sep 2, 2026

Dividend

$0.00

Beta (Volatility)

0.98 (Low)

Price

$1.02

Volume

1,498,805.447

Open

$1.08

Previous Close

$1.10

Daily Range

$1.00 - $1.12

52-Week Range

$0.49 - $2.45

Estimated Earnings Date

Sep 2, 2026

HOTH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Hoth Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Robbie Knie

Website

www.hoththerapeutics.com

Headquarters

New York City, NY 10020, US

HOTH Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-149%

Return on Capital

-3%

Return on Assets

-2%

Earnings Yield

-73.53%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$24.55M

Shares Outstanding

22.32M

Volume

1.50M

Avg. Volume

9.37M

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$11.11M

EBITDA

-$12.47M

Operating Cash Flow

-$9.80M

Capital Expenditure

$0.00

Free Cash Flow

-$9.80M

Cash & ST Invst.

$6.25M

Total Debt

$5.68K

Hoth Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$24.55M

N/A

Market Cap/Employee

$12.28M

N/A

Employees

N/A

Net Income

-$2.69M

+22.5%

EBITDA

-$2.69M

-1487649.7%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$4.05M

-64.2%

Total Debt

$0.00

-100.0%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-2.09%

N/A

Return on Invested Capital

-2.77%

N/A

Free Cash Flow

-$3.05M

-9.4%

Operating Cash Flow

-$3.05M

-9.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

DAREDaré Bioscience, Inc.

DAREDaré Bioscience, Inc.$2.11+1.26%

ENTOEntero Therapeutics, Inc.

ENTOEntero Therapeutics, Inc.$2.85-5.00%

BCTXBriaCell Therapeutics Corp.

BCTXBriaCell Therapeutics Corp.$2.94+5.00%

CRISCuris, Inc.

CRISCuris, Inc.$0.41+1.03%

PULMPulmatrix, Inc.

PULMPulmatrix, Inc.$1.47-2.00%

PCSAProcessa Pharmaceuticals, Inc.

PCSAProcessa Pharmaceuticals, Inc.$2.15-0.23%

FBLGFibroBiologics, Inc. Common Stock

FBLGFibroBiologics, Inc. Common Stock$0.80-0.53%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.34-0.04%

AALAmerican Airlines Group

AALAmerican Airlines Group$16.02+0.04%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.83-0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$82.99+0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$36.77-0.07%

INTCIntel

INTCIntel$133.79+0.10%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$179.43-0.06%

Questions About HOTH

What is the current price of Hoth Therapeutics?

Hoth Therapeutics is trading at $1.02 per share.

What is the 52-week range for Hoth Therapeutics?

Over the past 52 weeks, Hoth Therapeutics has traded between $0.49 and $2.45.

How much debt does Hoth Therapeutics have?

As of the most recent reporting period, Hoth Therapeutics reported total debt of $0.00.

How much cash does Hoth Therapeutics have on hand?

Hoth Therapeutics reported $4.05M in cash and cash equivalents in its most recent financial results.

What is Hoth Therapeutics’s dividend yield?

Hoth Therapeutics does not currently have a dividend yield.

Hoth Therapeutics

Hoth Therapeutics Financials at a Glance

HOTH News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Hoth Therapeutics

HOTH Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Hoth Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About HOTH

What is the current price of Hoth Therapeutics?

What is the 52-week range for Hoth Therapeutics?

How much debt does Hoth Therapeutics have?

How much cash does Hoth Therapeutics have on hand?

What is Hoth Therapeutics’s dividend yield?

Premium Investing Services